Linking cyclins to transcriptional control

Gene

Volumn 299, Issue 1-2, 2002, Pages 35-55

  Coqueret, Olivier ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Cell cycle; Cyclin D; Cyclin dependent kinase; Gene expression; p21waf1

Indexed keywords

CYCLIN D; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLINE; HISTONE DEACETYLASE; MITOGENIC AGENT; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR;

BREAST EPITHELIUM; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL FUNCTION; CELL GROWTH; CELLULAR PARAMETERS; DEVELOPMENTAL DISORDER; GENE CONTROL; GENE EXPRESSION; GENE INACTIVATION; GENETIC TRANSCRIPTION; NERVOUS SYSTEM; ONCOGENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; RETINA; REVIEW; SEQUENCE HOMOLOGY; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; ANIMALS; CELL CYCLE; CELL DIVISION; CYCLINS; GENE EXPRESSION REGULATION; HUMANS; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 0037121081     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(02)01055-7     Document Type: Review

References (207)

1. Adnane J., Shao Z., Robbins P.D. Cyclin D1 associates with the TBP-associated factor TAF(II)250 to regulate Sp1-mediated transcription. Oncogene. 18:1999;239-247.
2. Ait-Si-Ali S., Ramirez S., Barre F.X., Dkhissi F., Magnaghi-Jaulin L., Girault J.A., Robin P., Knibiehler M., Pritchard L.L., Ducommun B., Trouche D., Harel-Bellan A. Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A. Nature. 396:1998;184-186.
3. Aktas H., Cai H., Cooper G.M. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. Mol. Cell. Biol. 17:1997;3850-3857.
4. Albanese C., Johnson J., Watanabe G., Eklund N., Vu D., Arnold A., Pestell R.G. Transforming p21Ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270:1995;23589-23597.
5. Alt J.R., Cleveland J.L., Hannink M., Diehl J.A. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev. 14:2000;3102-3114.
6. Antman K., Chang Y. Kaposi's sarcoma. New Engl. J. Med. 342:2000;1027-1038.
7. Arnold A., Kim H.G., Gaz R.D., Eddy R.L., Fukushima Y., Byers M.G., Shows T.B., Kronenberg H.M. Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J. Clin. Invest. 83:1989;2034-2040.
8. Bagby S., Kim S., Maldonado E., Tong K.I., Reinberg D., Ikura M. Solution structure of the C-terminal core domain of human TFIIB: Similarity to cyclin A and interaction with TATA-binding protein. Cell. 82:1995;857-867.
9. Bakiri L., Lallemand D., Bossy-Wetzel E., Yaniv M. Cell cycle-dependent variations in c-Jun and JunB phosphorylation: A role in the control of cyclin D1 expression. EMBO J. 19:2000;2056-2068.
10. Barboric M., Nissen R.M., Kanazawa S., Jabrane-Ferrat N., Peterlin B.M. NF-kappaB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol. Cell. 8:2001;327-337.
11. Bartek J., Bartkova J., Lukas J. The retinoblastoma protein pathway and the restriction point. Curr. Opin. Cell Biol. 8:1996;805-814.
12. Bernards R. CDK-independent activities of D type cyclins. Biochim. Biophys. Acta. 1424:1999;M17-M22.
13. Betticher D.C., Thatcher N., Altermatt H.J., Hoban P., Ryder W.D., Heighway J. Alternate splicing produces a novel cyclin D1 transcript. Oncogene. 11:1995;1005-1011.
14. Betz B.L., Strobeck M.W., Reisman D.N., Knudsen E.S., Weissman B.E. Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB. Oncogene. 21:2002;5193-5203.
15. Bienvenu F., Gascan H., Coqueret O. Cyclin D1 represses STAT3 activation through a Cdk4-independent mechanism. J. Biol. Chem. 276:2001;16840-16847.
16. Bochar D.A., Pan Z.Q., Knights R., Fisher R.P., Shilatifard A., Shiekhattar R. Inhibition of transcription by the trimeric cyclin-dependent kinase 7 complex. J. Biol. Chem. 274:1999;13162-13166.
17. Bodrug S.E., Warner B.J., Bath M.L., Lindeman G.J., Harris A.W., Adams J.M. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the Myc gene. EMBO J. 13:1994;2124-2130.
18. Brehm A., Miska E.A., McCance D.J., Reid J.L., Bannister A.J., Kouzarides T. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature. 391:1998;597-601.
19. Bremner R., Cohen B.L., Sopta M., Hamel P.A., Ingles C.J., Gallie B.L., Phillips R.A. Direct transcriptional repression by pRB and its reversal by specific cyclins. Mol. Cell. Biol. 15:1995;3256-3265.
20. Bromberg J., Wrzeszczynska M., Devgan G., Zhao Y., Pestell R., Albanese C., Darnell J. Stat3 as an oncogene. Cell. 98:1999;295-303.
21. Brown N.R., Noble M.E., Endicott J.A., Garman E.F., Wakatsuki S., Mitchell E., Rasmussen B., Hunt T., Johnson L.N. The crystal structure of cyclin A. Structure. 3:1995;1235-1247.
22. Brumby A.M., Zraly C.B., Horsfield J.A., Secombe J., Saint R., Dingwall A.K., Richardson H. Drosophila cyclin E interacts with components of the Brahma complex. EMBO J. 21:2002;3377-3389.
23. Buckley M.F., Sweeney K.J., Hamilton J.A., Sini R.L., Manning D.L., Nicholson R.I., deFazio A., Watts C.K., Musgrove E.A., Sutherland R.L. Expression and amplification of cyclin genes in human breast cancer. Oncogene. 8:1993;2127-2133.
24. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature. 410:2001;37-40.
25. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., Moore P.S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 266:1994;1865-1869.
26. Chen D., Riedl T., Washbrook E., Pace P.E., Coombes R.C., Egly J.M., Ali S. Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Mol. Cell. 6:2000;127-137.
27. Chen S.L., Dowhan D.H., Hosking B.M., Muscat G.E. The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation. Genes Dev. 14:2000;1209-1228.
28. Chen S.L., Wang S.C., Hosking B., Muscat G.E. Subcellular localization of the steroid receptor coactivators (SRCs) and MEF2 in muscle and rhabdomyosarcoma cells. Mol. Endocrinol. 15:2001;783-796.
29. Cheng M., Sexl V., Sherr C.J., Roussel M.F. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc. Natl. Acad. Sci. USA. 95:1998;1091-1096.
30. Cheng M., Olivier P., Diehl J.A., Fero M., Roussel M.F., Roberts J.M., Sherr C.J. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18:1999;1571-1583.
31. Cockcroft C.E., den Boer B.G., Healy J.M., Murray J.A. Cyclin D control of growth rate in plants. Nature. 405:2000;575-579.
32. Conaway J.W., Shilatifard A., Dvir A., Conaway R.C. Control of elongation by RNA polymerase II. Trends Biochem. Sci. 25:2000;375-380.
33. Coqueret O., Gascan H. Functional interaction of STAT3 transcription factor with the cell cycle inhibitor p21WAF1/CIP1/SDI1. J. Biol. Chem. 275:2000;18794-18800.
34. Dai K., Kobayashi R., Beach D. Physical interaction of mammalian CDC37 with CDK4. J. Biol. Chem. 271:1996;22030-22034.
35. Datar S.A., Jacobs H.W., de la Cruz A.F., Lehner C.F., Edgar B.A. The Drosophila cyclin D-Cdk4 complex promotes cellular growth. EMBO J. 19:2000;4543-4554.
36. De Bondt H.L., Rosenblatt J., Jancarik J., Jones H.D., Morgan D.O., Kim S.H. Crystal structure of cyclin-dependent kinase 2. Nature. 363:1993;595-602.
37. Delavaine L., La Thangue N.B. Control of E2F activity by p21Waf1/Cip1. Oncogene. 18:1999;5381-5392.
38. Diehl J.A., Zindy F., Sherr C.J. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 11:1997;957-972.
39. Diehl J.A., Cheng M., Roussel M.F., Sherr C.J. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12:1998;3499-3511.
40. Dotto G.P. p21(WAF1/Cip1): More than a break to the cell cycle? Biochim. Biophys. Acta. 1471:2000;M43-M56.
41. Dowdy S.F., Hinds P.W., Louie K., Reed S.I., Arnold A., Weinberg R.A. Physical interaction of the retinoblastoma protein with human D cyclins. Cell. 73:1993;499-511.
42. Duman-Scheel M., Weng L., Xin S., Du W. Hedgehog regulates cell growth and proliferation by inducing cyclin D and cyclin E. Nature. 417:2002;299-304.
43. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 12:1998;2245-2262.
44. Eberhardy S.R., Farnham P.J. c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism. J. Biol. Chem. 276:2001;48562-48571.
45. Evans T., Rosenthal E.T., Youngblom J., Distel D., Hunt T. Cyclin: A protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division. Cell. 33:1983;389-396.
46. Ewen M.E. Where the cell cycle and histones meet. Genes Dev. 14:2000;2265-2270.
47. Ewen M.E., Sluss H.K., Sherr C.J., Matsushime H., Kato J., Livingston D.M. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell. 73:1993;487-497.
48. Fantl V., Richards M.A., Smith R., Lammie G.A., Johnstone G., Allen D., Gregory W., Peters G., Dickson C., Barnes D.M. Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer. Eur. J. Cancer. 26:1990;423-429.
49. Fantl V., Stamp G., Andrews A., Rosewell I., Dickson C. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 9:1995;2364-2372.
50. Felzien L.K., Farrell S., Betts J.C., Mosavin R., Nabel G.J. Specificity of cyclin E-Cdk2, TFIIB, and E1A interactions with a common domain of the p300 coactivator. Mol. Cell. Biol. 19:1999;4241-4246.
51. Filmus J., Robles A.I., Shi W., Wong M.J., Colombo L.L., Conti C.J. Induction of cyclin D1 overexpression by activated Ras. Oncogene. 9:1994;3627-3633.
52. Flemington E.K., Speck S.H., Kaelin W.G. Jr. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA. 90:1993;6914-6918.
53. Flore O., Rafii S., Ely S., O'Leary J.J., Hyjek E.M., Cesarman E. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature. 394:1998;588-592.
54. Foley E., Sprenger F. Cyclins: Growing pains for Drosophila. Curr. Biol. 10:2000;R665-R667.
55. Ganter B., Fu S., Lipsick J.S. D-type cyclins repress transcriptional activation by the v-Myb but not the c-Myb DNA-binding domain. EMBO J. 17:1998;255-268.
56. Gaughan L., Logan I.R., Cook S., Neal D.E., Robson C.N. Tip60 and histone deacetylase 1 regulate androgen receptor activity through changes to the acetylation status of the receptor. J. Biol. Chem. 277:2002;25904-25913.
57. Geng Y., Eaton E.N., Picon M., Roberts J.M., Lundberg A.S., Gifford A., Sardet C., Weinberg R.A. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene. 12:1996;1173-1180.
58. Geng Y., Whoriskey W., Park M.Y., Bronson R.T., Medema R.H., Li T., Weinberg R.A., Sicinski P. Rescue of cyclin D1 deficiency by knockin cyclin E. Cell. 97:1999;767-777.
59. Germain D., Russell A., Thompson A., Hendley J. Ubiquitination of free cyclin D1 is independent of phosphorylation on threonine 286. J. Biol. Chem. 275:2000;12074-12079.
60. Godden-Kent D., Talbot S.J., Boshoff C., Chang Y., Moore P., Weiss R.A., Mittnacht S. The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates Cdk6 to phosphorylate the retinoblastoma protein and histone H1. J. Virol. 71:1997;4193-4198.
61. Gottesfeld J.M., Forbes D.J. Mitotic repression of the transcriptional machinery. Trends Biochem. Sci. 22:1997;197-202.
62. Gu W., Roeder R.G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell. 90:1997;595-606.
63. Gudas J.M., Payton M., Thukral S., Chen E., Bass M., Robinson M.O., Coats S. Cyclin E2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers. Mol. Cell. Biol. 19:1999;612-622.
64. Guttridge D.C., Albanese C., Reuther J.Y., Pestell R.G., Baldwin A.S. Jr. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19:1999;5785-5799.
65. Haidweger E., Novy M., Rotheneder H. Modulation of Sp1 activity by a cyclin A/CDK complex. J. Mol. Biol. 306:2001;201-212.
66. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70.
67. Harbour J.W., Dean D.C. The Rb/E2F pathway: Expanding roles and emerging paradigms. Genes Dev. 14:2000;2393-2409.
68. Harbour J.W., Luo R.X., Dei Santi A., Postigo A.A., Dean D.C. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell. 98:1999;859-869.
69. Heix J., Vente A., Voit R., Budde A., Michaelidis T.M., Grummt I. Mitotic silencing of human rRNA synthesis: Inactivation of the promoter selectivity factor SL1 by cdc2/cyclin B-mediated phosphorylation. EMBO J. 17:1998;7373-7381.
70. Helin K., Harlow E., Fattaey A. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol. 13:1993;6501-6508.
71. Hinds P.W., Dowdy S.F., Eaton E.N., Arnold A., Weinberg R.A. Function of a human cyclin gene as an oncogene. Proc. Natl. Acad. Sci. USA. 91:1994;709-713.
72. Hoffmann I., Draetta G., Karsenti E. Activation of the phosphatase activity of human cdc25A by a Cdk2-cyclin E dependent phosphorylation at the G1/S transition. EMBO Journal. 13:1994;4302-4310.
73. Horstmann S., Ferrari S., Klempnauer K.H. Regulation of B-Myb activity by cyclin D1. Oncogene. 19:2000;298-306.
74. Hulit J., Bash T., Fu M., Galbiati F., Albanese C., Sage D.R., Schlegel A., Zhurinsky J., Shtutman M., Ben-Ze'ev A., Lisanti M.P., Pestell R.G. The cyclin D1 gene is transcriptionally repressed by caveolin-1. J. Biol. Chem. 275:2000;21203-21209.
75. Inoue K., Sherr C.J. Gene expression and cell cycle arrest mediated by transcription factor DMP1 is antagonized by D-type cyclins through a cyclin-dependent-kinase-independent mechanism. Mol. Cell. Biol. 18:1998;1590-1600.
76. Jeffrey P.D., Russo A.A., Polyak K., Gibbs E., Hurwitz J., Massague J., Pavletich N.P. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature. 376:1995;313-320.
77. Jinno S., Suto K., Nagata A., IgaRashi M., Kanaoka Y., Nojima H., Okayama H. Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J. 13:1994;1549-1556.
78. Kadonaga J.T. Eukaryotic transcription: An interlaced network of transcription factors and chromatin-modifying machines. Cell. 92:1998;307-313.
79. Kato J.Y., Sherr C.J. Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1. Proc. Natl. Acad. Sci. USA. 90:1993;11513-11517.
80. Kim T.Y., Kaelin W.G. Jr. Differential control of transcription by DNA-bound cyclins. Mol. Biol. Cell. 12:2001;2207-2217.
81. Kim H.A., Pomeroy S.L., Whoriskey W., Pawlitzky I., Benowitz L.I., Sicinski P., Stiles C.D., Roberts T.M. A developmentally regulated switch directs regenerative growth of Schwann cells through cyclin D1. Neuron. 26:2000;405-416.
82. King R.W., Deshaies R.J., Peters J.M., Kirschner M.W. How proteolysis drives the cell cycle. Science. 274:1996;1652-1659.
83. Kitaura H., Shinshi M., Uchikoshi Y., Ono T., Iguchi-Ariga S.M., Ariga H. Reciprocal regulation via protein-protein interaction between c-Myc and p21(cip1/waf1/sdi1) in DNA replication and transcription. J. Biol. Chem. 275:2000;10477-10483.
84. Knudsen K.E., Cavenee W.K., Arden K.C. D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability. Cancer Res. 59:1999;2297-2301.
85. Koepp D.M., Harper J.W., Elledge S.J. How the cyclin became a cyclin: Regulated proteolysis in the cell cycle. Cell. 97:1999;431-434.
86. Koff A., Cross F., Fisher A., Schumacher J., Leguellec K., Philippe M., Roberts J.M. Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell. 66:1991;1217-1228.
87. Krek W., Xu G., Livingston D.M. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell. 83:1995;1149-1158.
88. Kuhn A., Vente A., Doree M., Grummt I. Mitotic phosphorylation of the TBP-containing factor SL1 represses ribosomal gene transcription. J. Mol. Biol. 284:1998;1-5.
89. Labaer J., Garrett M.D., Stevenson L.F., Slingerland J.M., Sandhu C., Chou H.S., Fattaey A., Harlow E. New functional activities for the p21 family of cdk inhibitors. Genes Dev. 11:1997;847-862.
90. Laman H., Coverley D., Krude T., Laskey R., Jones N. Viral cyclin-cyclin-dependent kinase 6 complexes initiate nuclear DNA replication. Mol. Cell. Biol. 21:2001;624-635.
91. Lammie G.A., Fantl V., Smith R., Schuuring E., Brookes S., Michalides R., Dickson C., Arnold A., Peters G. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene. 6:1991;439-444.
92. Lavoie J.N., L'Allemain G., Brunet A., Muller R., Pouyssegur J. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271:1996;20608-20616.
93. Lavoie J.N., Rivard N., L'Allemain G., Pouyssegur J. A temporal and biochemical link between growth factor-activated MAP kinases, cyclin D1 induction and cell cycle entry. Prog. Cell Cycle Res. 2:1996;49-58.
94. Lazaro J.B., Bailey P.J., Lassar A.B. Cyclin D-Cdk4 activity modulates the subnuclear localization and interaction of MEF2 with SRC-family coactivators during skeletal muscle differentiation. Genes Dev. 16:2002;1792-1805.
95. Le Cam L., Polanowska J., Fabbrizio E., Olivier M., Philips A., Ng Eaton E., Classon M., Geng Y., Sardet C. Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex. EMBO J. 18:1999;1878-1890.
96. Lee R.J., Albanese C., Stenger R.J., Watanabe G., Inghirami G., Haines G.K.I.I.I., Webster M., Muller W.J., Brugge J.S., Davis R.J., Pestell R.G. pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells. J. Biol. Chem. 274:1999;7341-7350.
97. Lemon B., Tjian R. Orchestrated response: A symphony of transcription factors for gene control. Genes Dev. 14:2000;2551-2569.
98. Li M., Lee H., Yoon D.W., Albrecht J.C., Fleckenstein B., Neipel F., Jung J.U. Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. J. Virol. 71:1997;1984-1991.
99. Lin H.M., Zhao L., Cheng S.Y. Cyclin D1 is a ligand-independent co-repressor for thyroid hormone receptors. J. Biol. Chem. 4:2002;4.
100. Lin X., Taube R., Fujinaga K., Peterlin B.M. P-TEFb containing cyclin K and Cdk9 can activate transcription via RNA. J. Biol. Chem. 277:2002;16873-16878.
101. Lohka M.J., Hayes M.K., Maller J.L. Purification of maturation-promoting factor, an intracellular regulator of early mitotic events. Proc. Natl. Acad. Sci. USA. 85:1988;3009-3013.
102. Lovec H., Grzeschiczek A., Kowalski M.B., Moroy T. Cyclin D1/bcl-1 cooperates with Myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J. 13:1994;3487-3495.
103. Lovec H., Sewing A., Lucibello F.C., Muller R., Moroy T. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-Ras: Link between cell cycle control and malignant transformation. Oncogene. 9:1994;323-326.
104. Lundberg A.S., Weinberg R.A. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18:1998;753-761.
105. Luo R.X., Postigo A.A., Dean D.C. Rb interacts with histone deacetylase to repress transcription. Cell. 92:1998;463-473.
106. Maeda K., Chung Y., Kang S., Ogawa M., Onoda N., Nishiguchi Y., Ikehara T., Nakata B., Okuno M., Sowa M. Cyclin D1 overexpression and prognosis in colorectal adenocarcinoma. Oncology. 55:1998;145-151.
107. Magnaghi-Jaulin L., Groisman R., Naguibneva I., Robin P., Lorain S., Le Villain J.P., Troalen F., Trouche D., Harel-Bellan A. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature. 391:1998;601-605.
108. Mann D.J., Child E.S., Swanton C., Laman H., Jones N. Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus. EMBO J. 18:1999;654-663.
109. Martinez-Balbas M.A., Bauer U.M., Nielsen S.J., Brehm A., Kouzarides T. Regulation of E2F1 activity by acetylation. EMBO J. 19:2000;662-671.
110. Matsumura I., Kitamura T., Wakao H., Tanaka H., Hashimoto K., Albanese C., Downward J., Pestell R.G., Kanakura Y. Transcriptional regulation of the cyclin D1 promoter by STAT5: Its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J. 18:1999;1367-1377.
111. Matsushime H., Roussel M.F., Ashmun R.A., Sherr C.J. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell. 65:1991;701-713.
112. Matsushime H., Ewen M.E., Strom D.K., Kato J.Y., Hanks S.K., Roussel M.F., Sherr C.J. Identification and properties of an atypical catalytic subunit (p34PSK-J3/Cdk4) for mammalian D type G1 cyclins. Cell. 71:1992;323-334.
113. McMahon C., Suthiphongchai T., DiRenzo J., Ewen M.E. P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor. Proc. Natl. Acad. Sci. USA. 96:1999;5382-5387.
114. Meyer C.A., Jacobs H.W., Datar S.A., Du W., Edgar B.A., Lehner C.F. Drosophila Cdk4 is required for normal growth and is dispensable for cell cycle progression. EMBO J. 19:2000;4533-4542.
115. Miyazaki Y., Boccuni P., Mao S., Zhang J., Erdjument-Bromage H., Tempst P., Kiyokawa H., Nimer S.D. Cyclin A-dependent phosphorylation of the ETS-related protein, MEF, restricts its activity to the G1 phase of the cell cycle. J. Biol. Chem. 276:2001;40528-40536.
116. Moore J.C., Sumerel J.L., Schnackenberg B.J., Nichols J.A., Wikramanayake A., Wessel G.M., Marzluff W.F. Cyclin D and Cdk4 are required for normal development beyond the blastula stage in sea urchin embryos. Mol. Cell. Biol. 22:2002;4863-4875.
117. Morgan D.O. Principles of CDK regulation. Nature. 374:1995;131-134.
118. Morgan D.O. Cyclin-dependent kinases: Engines, clocks, and microprocessors. Annu. Rev. Cell Dev. Biol. 13:1997;261-291.
119. Motokura T., Arnold A. Cyclin D and oncogenesis. Curr. Opin. Genet. Dev. 3:1993;5-10.
120. Motokura T., Arnold A. PRAD1/cyclin D1 proto-oncogene: Genomic organization, 5′ DNA sequence, and sequence of a tumor-specific rearrangement breakpoint. Genes Chromosomes Cancer. 7:1993;89-95.
121. Motokura T., Bloom T., Kim H.G., Juppner H., Ruderman J.V., Kronenberg H.M., Arnold A. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature. 350:1991;512-515.
122. Nakajima T., Uchida C., Anderson S.F., Lee C.G., Hurwitz J., Parvin J.D., Montminy M. RNA helicase A mediates association of CBP with RNA polymerase II. Cell. 90:1997;1107-1112.
123. Neuman E., Ladha M.H., Lin N., Upton T.M., Miller S.J., DiRenzo J., Pestell R.G., Hinds P.W., Dowdy S.F., Brown M., Ewen M.E. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of Cdk4. Mol. Cell. Biol. 17:1997;5338-5347.
124. Nielsen S.J., Schneider R., Bauer U.M., Bannister A.J., Morrison A., O'Carroll D., Firestein R., Cleary M., Jenuwein T., Herrera R.E., Kouzarides T. Rb targets histone H3 methylation and HP1 to promoters. Nature. 412:2001;561-565.
125. Nikolov D.B., Chen H., Halay E.D., Usheva A.A., Hisatake K., Lee D.K., Roeder R.G., Burley S.K. Crystal structure of a TFIIB-TBP-TATA-element ternary complex. Nature. 377:1995;119-128.
126. Noble M.E., Endicott J.A., Brown N.R., Johnson L.N. The cyclin box fold: Protein recognition in cell-cycle and transcription control. Trends Biochem. Sci. 22:1997;482-487.
127. Nurse P. A long twentieth century of the cell cycle and beyond. Cell. 100:2000;71-78.
128. Nurse P., Bissett Y. Gene required in G1 for commitment to cell cycle and in G2 for control of mitosis in fission yeast. Nature. 292:1981;558-560.
129. Ohtani K., DeGregori J., Nevins J.R. Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci. USA. 92:1995;12146-12150.
130. Ojala P.M., Yamamoto K., Castanos-Velez E., Biberfeld P., Korsmeyer S.J., Makela T.P. The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2. Nat. Cell Biol. 2:2000;819-825.
131. Park M., Krause M.W. Regulation of postembryonic G(1) cell cycle progression in Caenorhabditis elegans by a cyclin D/CDK-like complex. Development. 126:1999;4849-4860.
132. Payton M., Coats S. Cyclin E2, the cycle continues. Int. J. Biochem. Cell Biol. 34:2002;315-320.
133. Peeper D.S., Upton T.M., Ladha M.H., Neuman E., Zalvide J., Bernards R., DeCaprio J.A., Ewen M.E. Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature. 386:1997;177-181.
134. Perkins N.D., Felzien L.K., Betts J.C., Leung K., Beach D.H., Nabel G.J. Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science. 275:1997;523-527.
135. Petre C.E., Wetherill Y.B., Danielsen M., Knudsen K.E. Cyclin D1: Mechanism and consequence of androgen receptor co-repressor activity. J. Biol. Chem. 277:2002;2207-2215.
136. Polymenis M., Schmidt E.V. Coupling of cell division to cell growth by translational control of the G1 cyclin CLN3 in yeast. Genes Dev. 11:1997;2522-2531.
137. Price D.H. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol. Cell. Biol. 20:2000;2629-2634.
138. Prober D.A., Edgar B.A. Growth regulation by oncogenes-new insights from model organisms. Curr. Opin. Genet. Dev. 11:2001;19-26.
139. Quelle D.E., Ashmun R.A., Shurtleff S.A., Kato J.Y., Bar-Sagi D., Roussel M.F., Sherr C.J. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev. 7:1993;1559-1571.
140. Rane S.G., Dubus P., Mettus R.V., Galbreath E.J., Boden G., Reddy E.P., Barbacid M. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat. Genet. 22:1999;44-52.
141. Ratineau C., Petry M.W., Mutoh H., Leiter A.B. Cyclin D1 represses the basic helix-loop-helix transcription factor, BETA2/NeuroD. J. Biol. Chem. 277:2002;8847-8853.
142. Resnitzky D., Gossen M., Bujard H., Reed S.I. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14:1994;1669-1679.
143. Reutens A.T., Fu M., Wang C., Albanese C., McPhaul M.J., Sun Z., Balk S.P., Janne O.A., Palvimo J.J., Pestell R.G. Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner. Mol. Endocrinol. 15:2001;797-811.
144. Robles A.I., Rodriguez-Puebla M.L., Glick A.B., Trempus C., Hansen L., Sicinski P., Tennant R.W., Weinberg R.A., Yuspa S.H., Conti C.J. Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic Ras pathway in vivo. Genes Dev. 12:1998;2469-2474.
145. Rochette-Egly C., Adam S., Rossignol M., Egly J.M., Chambon P. Stimulation of RAR alpha activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7. Cell. 90:1997;97-107.
146. Rosenberg C.L., Wong E., Petty E.M., Bale A.E., Tsujimoto Y., Harris N.L., Arnold A. PRAD1, a candidate BCL1 oncogene: Mapping and expression in centrocytic lymphoma. Proc. Natl. Acad. Sci. USA. 88:1991;9638-9642.
147. Rosenberg C.L., Motokura T., Kronenberg H.M., Arnold A. Coding sequence of the overexpressed transcript of the putative oncogene PRAD1/cyclin D1 in two primary human tumors. Oncogene. 8:1993;519-521.
148. Ross J.F., Liu X., Dynlacht B.D. Mechanism of transcriptional repression of E2F by the retinoblastoma tumor suppressor protein. Mol. Cell. 3:1999;195-205.
149. Ross J.F., Naar A., Cam H., Gregory R., Dynlacht B.D. Active repression and E2F inhibition by pRB are biochemically distinguishable. Genes Dev. 15:2001;392-397.
150. Rousseau D., Kaspar R., Rosenwald I., Gehrke L., Sonenberg N. Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E. Proc. Natl. Acad. Sci. USA. 93:1996;1065-1070.
151. Russell A., Thompson M.A., Hendley J., Trute L., Armes J., Germain D. Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer. Oncogene. 18:1999;1983-1991.
152. Russell P., Nurse P. cdc25+ functions as an inducer in the mitotic control of fission yeast. Cell. 45:1986;145-153.
153. Russell P., Nurse P. Negative regulation of mitosis by wee1+, a gene encoding a protein kinase homolog. Cell. 49:1987;559-567.
154. Sabbah M., Courilleau D., Mester J., Redeuilh G. Estrogen induction of the cyclin D1 promoter: Involvement of a cAMP response-like element. Proc. Natl. Acad. Sci. USA. 96:1999;11217-11222.
155. Sala A., Kundu M., Casella I., Engelhard A., Calabretta B., Grasso L., Paggi M.G., Giordano A., Watson R.J., Khalili K., Peschle C. Activation of human B-MYB by cyclins. Proc. Natl. Acad. Sci. USA. 94:1997;532-536.
156. Sano Y., Ishii S. Increased affinity of c-Myb for CREB-binding protein (CBP) after CBP-induced acetylation. J. Biol. Chem. 276:2001;3674-3682.
157. Santaguida M., Ding Q., Berube G., Truscott M., Whyte P., Nepveu A. Phosphorylation of the CCAAT displacement protein (CDP)/Cux transcription factor by cyclin A-Cdk1 modulates its DNA binding activity in G(2). J. Biol. Chem. 276:2001;45780-45790.
158. Schmelzle T., Hall M.N. TOR, a central controller of cell growth. Cell. 103:2000;253-262.
159. Shanahan F., Seghezzi W., Parry D., Mahony D., Lees E. Cyclin E associates with BAF155 and BRG1, components of the mammalian SWI-SNF complex, and alters the ability of BRG1 to induce growth arrest. Mol. Cell. Biol. 19:1999;1460-1469.
160. Shao Z., Robbins P.D. Differential regulation of E2F and Sp1-mediated transcription by G1 cyclins. Oncogene. 10:1995;221-228.
161. Sherr C.J. Mammalian G1 cyclins. Cell. 73:1993;1059-1065.
162. Sherr C.J. Cancer cell cycles. Science. 274:1996;1672-1677.
163. Sherr C.J., Roberts J.M. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev. 13:1999;1501-1512.
164. Shiekhattar R., Mermelstein F., Fisher R.P., Drapkin R., Dynlacht B., Wessling H.C., Morgan D.O., Reinberg D. Cdk-activating kinase complex is a component of human transcription factor TFIIH. Nature. 374:1995;283-287.
165. Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., Ben-Ze'ev A. The cyclin D1 gene is a target of the beta-catenin/lEF-1 pathway. Proc. Natl. Acad. Sci. USA. 96:1999;5522-5527.
166. Sicinski P., Donaher J.L., Parker S.B., Li T., Fazeli A., Gardner H., Haslam S.Z., Bronson R.T., Elledge S.J., Weinberg R.A. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell. 82:1995;621-630.
167. Siegert J.L., Rushton J.J., Sellers W.R., Kaelin W.G. Jr, Robbins P.D. Cyclin D1 suppresses retinoblastoma protein-mediated inhibition of TAFII250 kinase activity. Oncogene. 19:2000;5703-5711.
168. Sif S., Stukenberg P.T., Kirschner M.W., Kingston R.E. Mitotic inactivation of a human SWI/SNF chromatin remodeling complex. Genes Dev. 12:1998;2842-2851.
169. Skapek S.X., Rhee J., Spicer D.B., Lassar A.B. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science. 267:1995;1022-1024.
170. Skapek S.X., Rhee J., Kim P.S., Novitch B.G., Lassar A.B. Cyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation. Mol. Cell. Biol. 16:1996;7043-7053.
171. Smith C.L., Hager G.L. Transcriptional regulation of mammalian genes in vivo. A tale of two templates. J. Biol. Chem. 272:1997;27493-27496.
172. Snowden A.W., Anderson L.A., Webster G.A., Perkins N.D. A novel transcriptional repression domain mediates p21(WAF1/CIP1) induction of p300 transactivation. Mol. Cell. Biol. 20:2000;2676-2686.
173. Stepanova L., Leng X., Parker S.B., Harper J.W. Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4. Genes Dev. 10:1996;1491-1502.
174. Strahl B.D., Allis C.D. The language of covalent histone modifications. Nature. 403:2000;41-45.
175. Strobeck M.W., Knudsen K.E., Fribourg A.F., DeCristofaro M.F., Weissman B.E., Imbalzano A.N., Knudsen E.S. BRG-1 is required for RB-mediated cell cycle arrest. Proc. Natl. Acad. Sci. USA. 97:2000;7748-7753.
176. Struhl K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12:1999;599-606.
177. Swanton C., Mann D.J., Fleckenstein B., Neipel F., Peters G., Jones N. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature. 390:1997;184-187.
178. Tam S.W., Theodoras A.M., Shay J.W., Draetta G.F., Pagano M. Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: Association with Cdk4 is required for Cyclin D1 function in G1 progression. Oncogene. 9:1994;2663-2674.
179. Taube R., Lin X., Irwin D., Fujinaga K., Peterlin B.M. Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes. Mol. Cell. Biol. 22:2002;321-331.
180. Tetsu O., McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 398:1999;422-426.
181. Tsujimoto Y., Jaffe E., Cossman J., Gorham J., Nowell P.C., Croce C.M. Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature. 315:1985;340-343.
182. Vanwijnen A.J., Vangurp M.F., Deridder M.C., Tufarelli C., Last T.J., Birnbaum M., Vaughan P.S., Giordano A., Krek W., Neufeld E.J., Stein J.L., Stein G.S. Cdp/Cut is the DNA-binding subunit of histone gene transcription factor Hinf-D - A mechanism for gene regulation at the G(1)/S phase cell cycle transition point independent of transcription factor E2f. Proc. Natl. Acad. Sci. USA. 93:1996;11516-11521.
183. Vignali M., Hassan A.H., Neely K.E., Workman J.L. ATP-dependent chromatin-remodeling complexes. Mol. Cell. Biol. 20:2000;1899-1910.
184. Wang Y., Prives C. Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Nature. 376:1995;88-91.
185. Wang T.C., Cardiff R.D., Zukerberg L., Lees E., Arnold A., Schmidt E.V. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature. 369:1994;669-671.
186. Wang C., Fu M., Angeletti R.H., Siconolfi-Baez L., Reutens A.T., Albanese C., Lisanti M.P., Katzenellenbogen B.S., Kato S., Hopp T., Fuqua S.A., Lopez G.N., Kushner P.J., Pestell R.G. Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity. J. Biol. Chem. 276:2001;18375-18383.
187. Wang C., Fu M., D'Amico M., Albanese C., Zhou J.N., Brownlee M., Lisanti M.P., Chatterjee V.K., Lazar M.A., Pestell R.G. Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1. Mol. Cell. Biol. 21:2001;3057-3070.
188. Wassarman D.A., Sauer F. TAF(II)250: A transcription toolbox. J Cell Sci. 114:2001;2895-2902.
189. Watanabe G., Albanese C., Lee R.J., Reutens A., Vairo G., Henglein B., Pestell R.G. Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1. Mol. Cell. Biol. 18:1998;3212-3222.
190. Wei P., Garber M.E., Fang S.M., Fischer W.H., Jones K.A. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell. 92:1998;451-462.
191. Weintraub S.J., Prater C.A., Dean D.C. Retinoblastoma protein switches the E2F site from positive to negative element. Nature. 358:1992;259-261.
192. Weintraub S.J., Chow K.N., Luo R.X., Zhang S.H., He S., Dean D.C. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature. 375:1995;812-815.
193. Xiong Y., Connolly T., Futcher B., Beach D. Human D-type cyclin. Cell. 65:1991;691-699.
194. Yamamoto A., Hashimoto Y., Kohri K., Ogata E., Kato S., Ikeda K., Nakanishi M. Cyclin E as a coactivator of the androgen receptor. J. Cell Biol. 150:2000;873-880.
195. Yan Y.X., Nakagawa H., Lee M.H., Rustgi A.K. Transforming growth factor-alpha enhances cyclin D1 transcription through the binding of early growth response protein to a cis-regulatory element in the cyclin D1 promoter. J. Biol. Chem. 272:1997;33181-33190.
196. Yankulov K.Y., Bentley D.L. Regulation of CDK7 substrate specificity by MAT1 and TFIIH. EMBO J. 16:1997;1638-1646.
197. Yu Z.K., Gervais J.L., Zhang H. Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins. Proc. Natl. Acad. Sci. USA. 95:1998;11324-11329.
198. Yu Q., Geng Y., Sicinski P. Specific protection against breast cancers by cyclin D1 ablation. Nature. 411:2001;1017-1021.
199. Zhang H., Hannon G.J., Beach D. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8:1994;1750-1758.
200. Zhang J.M., Wei Q., Zhao X., Paterson B.M. Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with Cdk4. EMBO J. 18:1999;926-933.
201. Zhang H.S., Gavin M., Dahiya A., Postigo A.A., Ma D., Luo R.X., Harbour J.W., Dean D.C. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell. 101:2000;79-89.
202. Zhang Z.K., Davies K.P., Allen J., Zhu L., Pestell R.G., Zagzag D., Kalpana G.V. Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5. Mol. Cell. Biol. 22:2002;5975-5988.
203. Zhao J., Dynlacht B., Imai T., Hori T., Harlow E. Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry. Genes Dev. 12:1998;456-461.
204. Zhao J., Kennedy B.K., Lawrence B.D., Barbie D.A., Matera A.G., Fletcher J.A., Harlow E. NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. Genes Dev. 14:2000;2283-2297.
205. Zwicker J., Brusselbach S., Jooss K.U., Sewing A., Behn M., Lucibello F.C., Muller R. Functional domains in cyclin D1: pRb-kinase activity is not essential for transformation. Oncogene. 18:1999;19-25.
206. Zwijsen R.M., Wientjens E., Klompmaker R., van der Sman J., Bernards R., Michalides R.J. CDK-independent activation of estrogen receptor by cyclin D1. Cell. 88:1997;405-415.
207. Zwijsen R.M., Buckle R.S., Hijmans E.M., Loomans C.J., Bernards R. Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1. Genes Dev. 12:1998;3488-3498.